PMID- 22841916 OWN - NLM STAT- MEDLINE DCOM- 20130211 LR - 20231213 IS - 1873-7064 (Electronic) IS - 0028-3908 (Linking) VI - 64 DP - 2013 Jan TI - Chronic caffeine prevents changes in inhibitory avoidance memory and hippocampal BDNF immunocontent in middle-aged rats. PG - 153-9 LID - S0028-3908(12)00345-0 [pii] LID - 10.1016/j.neuropharm.2012.07.010 [doi] AB - Beneficial effects of caffeine on memory processes have been observed in animal models relevant to neurodegenerative diseases and aging, although the underlying mechanisms remain unknown. Because brain-derived neurotrophic factor (BDNF) is associated with memory formation and BDNF's actions are modulated by adenosine receptors, the molecular targets for the psychostimulant actions of caffeine, we here compare the effects of chronic caffeine (1 mg/mL drinking solution for 30 days) on short- and long term memory and on levels of hippocampal proBDNF, mature BDNF, TrkB and CREB in young (3 month old) and middle-aged (12 month old) rats. Caffeine treatment substantially reduced i) age-related impairments in the two types of memory in an inhibitory avoidance paradigm, and ii) parallel increases in hippocampal BDNF levels. In addition, chronic caffeine increased proBDNF and CREB concentrations, and decreased TrkB levels, in hippocampus regardless of age. These data provide new evidence in favor of the hypothesis that modifications in BDNF and related proteins in the hippocampus contribute to the pro-cognitive effects of caffeine on age-associated losses in memory encoding. This article is part of a Special Issue entitled 'Cognitive Enhancers'. CI - Copyright (c) 2012 Elsevier Ltd. All rights reserved. FAU - Sallaberry, Cassia AU - Sallaberry C AD - Laboratory of Studies on the Purinergic System, Department of Biochemistry, Health and Basic Sciences Institute, Federal University of Rio Grande do Sul, Rua Ramiro Barcelos, 2600-anexo, Porto Alegre, RS 90035 003, Brazil. FAU - Nunes, Fernanda AU - Nunes F FAU - Costa, Marcelo S AU - Costa MS FAU - Fioreze, Gabriela T AU - Fioreze GT FAU - Ardais, Ana Paula AU - Ardais AP FAU - Botton, Paulo Henrique S AU - Botton PH FAU - Klaudat, Bruno AU - Klaudat B FAU - Forte, Thomas AU - Forte T FAU - Souza, Diogo O AU - Souza DO FAU - Elisabetsky, Elaine AU - Elisabetsky E FAU - Porciuncula, Lisiane O AU - Porciuncula LO LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20120727 PL - England TA - Neuropharmacology JT - Neuropharmacology JID - 0236217 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Creb1 protein, rat) RN - 0 (Central Nervous System Stimulants) RN - 0 (Cyclic AMP Response Element-Binding Protein) RN - 0 (Nootropic Agents) RN - 0 (Protein Precursors) RN - 0 (brain-derived neurotrophic factor precursor) RN - 3G6A5W338E (Caffeine) RN - EC 2.7.10.1 (Receptor, trkB) SB - IM MH - *Aging MH - Animals MH - Avoidance Learning MH - Behavior, Animal MH - Brain-Derived Neurotrophic Factor/*metabolism MH - Caffeine/*therapeutic use MH - Central Nervous System Stimulants/therapeutic use MH - Cognitive Dysfunction/metabolism/*prevention & control MH - Cyclic AMP Response Element-Binding Protein/metabolism MH - Hippocampus/growth & development/*metabolism MH - Male MH - Memory, Long-Term MH - Memory, Short-Term MH - Neural Inhibition MH - Neurons/*metabolism MH - Nootropic Agents/*therapeutic use MH - Protein Precursors/*metabolism MH - Rats MH - Rats, Wistar MH - Receptor, trkB/metabolism EDAT- 2012/07/31 06:00 MHDA- 2013/02/12 06:00 CRDT- 2012/07/31 06:00 PHST- 2012/04/01 00:00 [received] PHST- 2012/07/03 00:00 [revised] PHST- 2012/07/04 00:00 [accepted] PHST- 2012/07/31 06:00 [entrez] PHST- 2012/07/31 06:00 [pubmed] PHST- 2013/02/12 06:00 [medline] AID - S0028-3908(12)00345-0 [pii] AID - 10.1016/j.neuropharm.2012.07.010 [doi] PST - ppublish SO - Neuropharmacology. 2013 Jan;64:153-9. doi: 10.1016/j.neuropharm.2012.07.010. Epub 2012 Jul 27.